immune system
• thymi contain CD3+ gamma/delta TCR+ cells, in contrast to some published reports
|
• thymocytes are unable to be activated by anti-CD3epsilon antibody treatment
|
• 5.3-fold reduction in numbers found in the thymus
|
• there is a strict developmental block in double negative T cells at the transition from the CD44-negative,CD25-positive stage to the CD44-, CD25- negative stage
|
• fewer gamma/delta T cells are present compared to wild-type thymi; progeny of these cells are subsequently lost before reaching periphery
|
• double-positive T cells are completely absent
|
• no single-positive cells are found in the thymus
|
• no single-positive cells are found in the thymus
|
• no gamma-delta T cells are found in the periphery
|
• abnormal T cell expansion indicates a lymphoproliferative disorder, associated with a Th2-like polarization (increased Il4 expression)
|
• spleens lack gamma/delta T cells
|
• lymph nodes lack gamma/delta T cells
|
hematopoietic system
• thymi contain CD3+ gamma/delta TCR+ cells, in contrast to some published reports
|
• thymocytes are unable to be activated by anti-CD3epsilon antibody treatment
|
• 5.3-fold reduction in numbers found in the thymus
|
• there is a strict developmental block in double negative T cells at the transition from the CD44-negative,CD25-positive stage to the CD44-, CD25- negative stage
|
• fewer gamma/delta T cells are present compared to wild-type thymi; progeny of these cells are subsequently lost before reaching periphery
|
• double-positive T cells are completely absent
|
• no single-positive cells are found in the thymus
|
• no single-positive cells are found in the thymus
|
• no gamma-delta T cells are found in the periphery
|
• abnormal T cell expansion indicates a lymphoproliferative disorder, associated with a Th2-like polarization (increased Il4 expression)
|
• spleens lack gamma/delta T cells
|
endocrine/exocrine glands
• thymi contain CD3+ gamma/delta TCR+ cells, in contrast to some published reports
|
• thymocytes are unable to be activated by anti-CD3epsilon antibody treatment
|